Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01356940 · ClinicalTrials.gov registry record · Phase 4
A Placebo Controlled Trial of Dalfampridine ER for Ambulatory Activity in People With Multiple Sclerosis
A Phase 4 study, sponsored by Brown, Theodore R., M.D., MPH.
- Completed
- Registry status
- Phase 4
- Development phase
- 43
- Enrollment target
NCT01356940 is a Phase 4 study that has completed, run by Brown, Theodore R., M.D., MPH. The registered enrollment target is 43 participants.
The verdict
NCT01356940, a Phase 4 study, has completed, sponsored by Brown, Theodore R., M.D., MPH.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 43 participants
- Enrollment target
Study Summary
A randomized placebo controlled double-blind cross-over trial of Dalfampridine ER for effect on ambulatory activity in people with multiple sclerosis
Interventions
- DRUG placebo
- DRUG dalfampridine ER
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2010-11 |
| Est. Completion | 2013-04 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01356940
The ClinicalTrials.gov registry entry for NCT01356940 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 43 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brown, Theodore R., M.D., MPH, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT01356940 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01356940 about?
NCT01356940 is a clinical study titled "A Placebo Controlled Trial of Dalfampridine ER for Ambulatory Activity in People With Multiple Sclerosis". A randomized placebo controlled double-blind cross-over trial of Dalfampridine ER for effect on ambulatory activity in people with multiple sclerosis
What is the current status of trial NCT01356940?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 43 participants. The study started on 2010-11. Estimated completion is 2013-04.
What interventions are being tested in trial NCT01356940?
The interventions under investigation include: placebo (DRUG), dalfampridine ER (DRUG).
Who is sponsoring clinical trial NCT01356940?
This trial is sponsored by Brown, Theodore R., M.D., MPH, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.